By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MabVax Therapeutics, Inc. 

11588 Sorrento Valley Road
Suite 20
San Diego  California  92121  U.S.A
Phone: 858-259-9405 Fax:



Company News
MabVax Therapeutics, Inc. Enters Agreements With Memorial Sloan-Kettering Cancer Center And Juno Therapeutics For Development Of Anti-Cancer Therapeutics 9/10/2014 8:14:07 AM
MabVax Therapeutics, Inc. Receives Stockholder Approval For Name Change And Reverse Stock Split Resulting From Merger With Telik, Inc. (TELK) 9/9/2014 9:05:58 AM
Telik, Inc. (TELK) Announces New Board Of Director Members To Oversee Reinvigorated Cancer Therapy Pipeline Resulting From The Recent Merger With MabVax Therapeutics, Inc. 8/11/2014 8:56:23 AM
Telik, Inc. (TELK) Announces Plans For Special Meeting Of Stockholders And Transition To MabVax Therapeutics, Inc. 8/4/2014 7:34:50 AM
Mintz Levin Represents San Diego-Based MabVax Therapeutics, Inc. In IPO Through Merger With Telik, Inc. (TELK) 7/11/2014 9:27:42 AM
MabVax Therapeutics, Inc. Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants 7/9/2014 10:24:09 AM
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014 9:53:19 AM
Telik, Inc. (TELK) And MabVax Therapeutics, Inc. Announce Definitive Merger Agreement 5/13/2014 9:16:53 AM
MabVax Therapeutics, Inc. Receives $1,750,000 Small Business Innovation Research Contract Award From National Cancer Institute to Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent 9/24/2013 9:51:59 AM
MabVax Therapeutics, Inc. Receives SBIR Program Award From the National Cancer Institute to Manufacture Clinical Supplies for Phase 2 Neuroblastoma Trial 12/18/2012 8:47:55 AM